MyAverix Finance
SHG · Healthcare
Nanjing Vazyme Biotech Co Ltd (688105)
Biotechnology
Nanjing Vazyme Biotech Co Ltd (688105) is listed on SHG in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $7.72B, P/E ratio is 18.00, net margin is -1.2%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 688105
Nanjing Vazyme Biotech Co Ltd (688105) — FAQ
What is Nanjing Vazyme Biotech Co Ltd's market cap?
Nanjing Vazyme Biotech Co Ltd (688105) has a reported market cap of $7.72B (data as of 2026-03-29).
What is 688105's P/E ratio?
The price-to-earnings (P/E) ratio for Nanjing Vazyme Biotech Co Ltd (688105) is 18.00 (data as of 2026-03-29).
Does Nanjing Vazyme Biotech Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Nanjing Vazyme Biotech Co Ltd (688105). Check the MyAverix Finance app for the latest dividend data.
What sector is Nanjing Vazyme Biotech Co Ltd in?
Nanjing Vazyme Biotech Co Ltd (688105) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 688105 listed on?
688105 is listed on SHG.
What is Nanjing Vazyme Biotech Co Ltd's net margin?
Nanjing Vazyme Biotech Co Ltd (688105) reports a net margin of -1.2% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.